Active Biotech AB (publ) (FRA:BTPC)
Germany flag Germany · Delayed Price · Currency is EUR
0.0036
-0.0001 (-2.70%)
At close: Jan 22, 2026

Active Biotech AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
9.127.436.2241.853.1326.21
Cash & Short-Term Investments
9.127.436.2241.853.1326.21
Cash Growth
46.77%-24.36%-13.35%-21.34%102.70%-56.08%
Accounts Receivable
-----0.28
Other Receivables
5.19.51.260.951.191.23
Receivables
5.19.51.260.951.191.51
Prepaid Expenses
-2.321.241.381.531.5
Other Current Assets
-----1.06
Total Current Assets
14.239.2138.7144.1255.8630.28
Property, Plant & Equipment
2.23.354.726.260.951.87
Other Intangible Assets
0.20.250.250.25--
Other Long-Term Assets
0.40.380.380.3800
Total Assets
1743.1844.0551.0156.832.16
Accounts Payable
-1.453.173.532.762.85
Accrued Expenses
-5.445.366.375.984.75
Current Portion of Leases
-1.651.551.610.761.31
Other Current Liabilities
12.10.360.30.560.410.44
Total Current Liabilities
12.18.9110.3812.069.99.35
Long-Term Leases
0.41.5334.430.230.69
Total Liabilities
12.510.4413.3816.4910.1310.04
Common Stock
4.56.351.871.371.130.75
Additional Paid-In Capital
-3,5093,4723,4313,3863,312
Retained Earnings
--3,483-3,443-3,398-3,340-3,291
Shareholders' Equity
4.532.7430.6734.5146.6722.11
Total Liabilities & Equity
1743.1844.0551.0156.832.16
Total Debt
0.43.184.556.040.992
Net Cash (Debt)
8.724.2131.6735.7652.1524.21
Net Cash Growth
102.33%-23.56%-11.42%-31.43%115.38%-57.09%
Net Cash Per Share
0.010.060.120.150.240.14
Filing Date Shares Outstanding
1,2301,230361.74264.89217.97217.97
Total Common Shares Outstanding
1,2301,066361.74264.89217.97145.24
Working Capital
2.130.328.3332.0645.9520.93
Book Value Per Share
0.000.030.080.130.210.15
Tangible Book Value
4.332.530.4234.2746.6722.11
Tangible Book Value Per Share
0.000.030.080.130.210.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.